Santhera Pharmaceuticals Holding AG
SIX:SANN
Cash Flow Statement
Cash Flow Statement
Santhera Pharmaceuticals Holding AG
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
(54)
|
(53)
|
(18)
|
(23)
|
(67)
|
(56)
|
(55)
|
(64)
|
(71)
|
(65)
|
55
|
63
|
(42)
|
(65)
|
|
| Depreciation & Amortization |
4
|
4
|
5
|
5
|
7
|
7
|
4
|
4
|
10
|
10
|
3
|
4
|
6
|
6
|
|
| Stock-Based Compensation |
7
|
11
|
6
|
5
|
3
|
0
|
3
|
4
|
5
|
6
|
6
|
7
|
3
|
4
|
|
| Other Non-Cash Items |
7
|
9
|
7
|
5
|
2
|
0
|
(19)
|
(23)
|
4
|
5
|
(19)
|
(19)
|
7
|
8
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash Interest Paid |
3
|
3
|
4
|
5
|
3
|
3
|
2
|
1
|
3
|
2
|
8
|
8
|
3
|
4
|
|
| Change in Working Capital |
5
|
4
|
9
|
17
|
14
|
7
|
33
|
52
|
27
|
16
|
9
|
(1)
|
(7)
|
11
|
|
| Cash from Operating Activities |
(38)
N/A
|
(36)
+5%
|
3
N/A
|
3
+16%
|
(44)
N/A
|
(42)
+3%
|
(37)
+12%
|
(31)
+18%
|
(30)
+3%
|
(33)
-11%
|
47
N/A
|
47
+0%
|
(36)
N/A
|
(41)
-15%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(22)
|
(20)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(4)
|
0
|
(24)
|
(24)
|
(0)
|
(0)
|
|
| Other Items |
16
|
16
|
3
|
3
|
2
|
0
|
0
|
0
|
0
|
6
|
6
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(6)
N/A
|
(5)
+22%
|
3
N/A
|
3
+2%
|
2
-45%
|
(0)
N/A
|
0
N/A
|
0
+109%
|
(4)
N/A
|
2
N/A
|
(18)
N/A
|
(24)
-31%
|
(0)
+100%
|
(0)
-133%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
22
|
31
|
7
|
(0)
|
(0)
|
0
|
20
|
20
|
(4)
|
(1)
|
19
|
16
|
1
|
1
|
|
| Net Issuance of Debt |
0
|
4
|
(1)
|
1
|
23
|
34
|
32
|
19
|
18
|
22
|
(19)
|
(26)
|
20
|
20
|
|
| Other |
(2)
|
(4)
|
(2)
|
0
|
(0)
|
(3)
|
(6)
|
(4)
|
(0)
|
(0)
|
(0)
|
(0)
|
25
|
23
|
|
| Cash from Financing Activities |
21
N/A
|
31
+51%
|
4
-87%
|
1
-74%
|
23
+2 066%
|
31
+34%
|
46
+48%
|
35
-23%
|
14
-60%
|
20
+46%
|
(0)
N/A
|
(11)
-6 045%
|
46
N/A
|
45
-3%
|
|
| Change in Cash | |||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
2
|
0
|
(2)
|
|
| Net Change in Cash |
(23)
N/A
|
(9)
+60%
|
9
N/A
|
7
-29%
|
(19)
N/A
|
(11)
+40%
|
9
N/A
|
5
-47%
|
(20)
N/A
|
(11)
+44%
|
29
N/A
|
15
-49%
|
11
-29%
|
2
-82%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(60)
N/A
|
(56)
+5%
|
2
N/A
|
3
+19%
|
(44)
N/A
|
(42)
+3%
|
(37)
+12%
|
(31)
+18%
|
(34)
-10%
|
(33)
+2%
|
24
N/A
|
24
+0%
|
(36)
N/A
|
(41)
-15%
|
|